$ARIA ARIAD Announces Approval of Iclusig (as Ponatinib Hydrochloride) in Canada CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 6, 2015-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA), today announced that Health Canada has approved the use of Iclusig™ (as ponatinib hydrochloride) in Canada ... http://www.noodls.com/view/3C3252D8FFE3BCB08D...6368286B1D